UAMS' Michael Birrer, M.D., Ph.D., Publishes Study Results in JAMA Oncology on Treatment for Incurable Cervical Cancer
July 26, 2024
July 26, 2024
LITTLE ROCK, Arkansas, July 26 (TNSres) -- The University of Arkansas for Medical Sciences issued the following news release on July 25, 2024:
The results of an international clinical trial led by Michael Birrer, M.D., Ph.D., director of the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS), on the use of a novel bispecific antibody for women with recurrent or metastatic cervical cancer were published today in JAMA Oncology.
The results of an international clinical trial led by Michael Birrer, M.D., Ph.D., director of the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS), on the use of a novel bispecific antibody for women with recurrent or metastatic cervical cancer were published today in JAMA Oncology.